States

Latest KFF Health News Stories

KFF Health News' 'What the Health?': Biden Wins Early Court Test for Medicare Drug Negotiations

Podcast

A federal district court judge dismissed a lawsuit attempting to invalidate the Biden administration’s Medicare prescription-drug price negotiation program. But the suit turned on a technicality, and several more court challenges are in the pipeline. Meanwhile, health policy pops up in Super Bowl ads, as Congress approaches yet another funding deadline. Alice Miranda Ollstein of Politico, Lauren Weber of The Washington Post, and Rachel Cohrs of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.

States Get in on the Prior Authorization Crackdown

KFF Health News Original

Last month, my colleague Lauren Sausser told you about the Biden administration’s crackdown on insurance plans’ prior authorization policies, with new rules for certain health plans participating in federal programs such as Medicare Advantage or the Affordable Care Act marketplace. States are getting in on the action, too. Prior authorization, sometimes called pre-certification, requires patients […]

New Eligibility Rules Are a Financial Salve for Nearly 2 Million on Medi-Cal

KFF Health News Original

Nearly 2 million Medi-Cal enrollees, mainly people who are aged, disabled, or in long-term care, can now accumulate savings and property without limitations and still qualify for the state’s health insurance program for low-income residents. They join an additional roughly 12 million enrollees who already had no asset limits.

KFF Health News' 'What the Health?': To End School Shootings, Activists Consider a New Culprit: Parents

Podcast

For the first time, a jury has convicted a parent of a school shooter of charges related to the child’s crime, finding a mother in Michigan guilty of involuntary manslaughter and possibly opening a new legal avenue for gun control advocates. Meanwhile, as the Supreme Court prepares to hear a case challenging the FDA’s approval of the abortion drug mifepristone, a medical publisher has retracted some of the journal studies that lower-court judges relied on in their decisions. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Rachana Pradhan of KFF Health News join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.